Proteomic Differences Between Heart Failure With Preserved Ejection Fraction Patients and Comorbidity Controls

被引：0
|
作者：
Swat, Stanley A. [1 ]
Njoroge, Joyce [1 ]
Sanchez, Cynthia L. [1 ]
Shah, Sanjiv J. [1 ]
机构：
[1] Northwestern Univ, Cardiol, Chicago, IL 60611 USA
来源：
CIRCULATION | 2018年 / 138卷
关键词：
Heart failure; Biomarkers; Inflammation;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16584
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction
    Scherbakov, Nadja
    Bauer, Maximiliane
    Sandek, Anja
    Szabo, Tibor
    Toepper, Agnieszka
    Jankowska, Ewa A.
    Springer, Jochen
    von Haehling, Stephan
    Anker, Stefan D.
    Lainscak, Mitja
    Engeli, Stefan
    Duengen, Hans-Dirk
    Doehner, Andwolfram
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (10) : 1015 - 1021
  • [22] Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction
    Pandey, Ambarish
    Omar, Wally
    Ayers, Colby
    LaMonte, Michael
    Klein, Liviu
    Allen, Norrina B.
    Kuller, Lewis H.
    Greenland, Philip
    Eaton, Charles B.
    Gottdiener, John S.
    Lloyd-Jones, Donald M.
    Berry, Jarett D.
    CIRCULATION, 2018, 137 (17) : 1814 - +
  • [23] Spironolactone in patients with heart failure and preserved ejection fraction
    Sanchez-Sanchez, C.
    Mendoza-Ruiz de Zuazu, H. F.
    Formiga, F.
    Manzano, L.
    Ceresuela, L. M.
    Carrera-Izquierdo, M.
    Gonzalez Franco, A.
    Epelde-Gonzalo, F.
    Cerqueiro-Gonzalez, J. M.
    Montero-Perez-Barquero, M.
    REVISTA CLINICA ESPANOLA, 2015, 215 (06): : 301 - 307
  • [24] Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction
    Nanayakkara, Shane
    Patel, Hitesh C.
    Kaye, David M.
    CLINICAL MEDICINE INSIGHTS-CARDIOLOGY, 2018, 12
  • [25] Treatment of patients with heart failure and preserved ejection fraction
    Deswal A.
    Bozkurt B.
    Current Treatment Options in Cardiovascular Medicine, 2008, 10 (6) : 516 - 528
  • [26] Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
    Poppe, Katrina K.
    Doughty, Robert N.
    HEART FAILURE CLINICS, 2014, 10 (03) : 503 - +
  • [27] Irbesartan in patients with heart failure and preserved ejection fraction
    Forman D.
    Gaziano J.M.
    Current Cardiovascular Risk Reports, 2009, 3 (5) : 311 - 312
  • [28] Spironolactone in patients with heart failure and preserved ejection fraction
    Nunez, J.
    Nunez, E.
    Sanchis, J.
    REVISTA CLINICA ESPANOLA, 2016, 216 (02): : 111 - 111
  • [29] Reduced muscle strength and quality of life in patients with heart failure with preserved ejection fraction compared to healthy controls and patients with heart failure and reduced ejection fraction
    Bekfani, T.
    Derlien, S.
    Hamadanchi, A.
    Nisser, J.
    Froeb, E.
    Smolenski, U. C.
    Lehmann, G.
    Wolf, G.
    Moebius-Winkler, S.
    Schulze, P. C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 276 - 276
  • [30] Hypoxaemia in patients with heart failure and preserved ejection fraction
    Omar, Massar
    Omote, Kazunori
    Sorimachi, Hidemi
    Popovic, Dejana
    Kanwar, Ardaas
    Alogna, Alessio
    Reddy, Yogesh N. V.
    Lim, Kaiser G.
    Shah, Sanjiv J.
    Borlaug, Barry A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (09) : 1593 - 1603
12345